Health and Fitness Health and Fitness
Mon, July 23, 2012
[ Mon, Jul 23rd 2012 ] - Market Wire
Ronald L. Chez Files Amended 13D and Letter to the Board
[ Mon, Jul 23rd 2012 ] - Market Wire
Sunshine Heart Announces First Patient Reaches Tw .. Follow-Up Mark for C-Pulse(R) Heart Assist System
[ Mon, Jul 23rd 2012 ] - Market Wire
Implant Sciences Extends Global Distribution Network Into Switzerland
[ Mon, Jul 23rd 2012 ] - Market Wire
InternetArray Appoints StockPlay Director of Marketing
[ Mon, Jul 23rd 2012 ] - Market Wire
Mexico Grants Quick-Med Technologies Additional NIMBUS(R) Patent
[ Mon, Jul 23rd 2012 ] - Market Wire
Trimel Completes Patient Enrolment of CompleoTRT(TM) Phase III Trial
[ Mon, Jul 23rd 2012 ] - Market Wire
Life Technologies Develops Simplified SAME-DAY ST .. ecting Multiple Strains of E. coli in Ground Beef
[ Mon, Jul 23rd 2012 ] - Market Wire
Isis Pharmaceuticals' Second Quarter 2012 Financial Results Conference Call
[ Mon, Jul 23rd 2012 ] - Market Wire
OncoSec OMS ElectroChemotherapy for Head and Neck .. ality of Life in Two Randomized Phase III Studies
[ Mon, Jul 23rd 2012 ] - Market Wire
BioLife Solutions Completes Corporate Facilities .. of Additional cGMP Clean Room Manufacturing Suite
Sun, July 22, 2012
[ Sun, Jul 22nd 2012 ] - Market Wire
Basilea announces completion of Toctino(R) (alitretinoin) transaction with Stiefel
Sat, July 21, 2012
[ Sat, Jul 21st 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 Investing in Centene Corporation To Contact
Fri, July 20, 2012
[ Fri, Jul 20th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. cess of $100,000 Investing in Centene Corporation
[ Fri, Jul 20th 2012 ] - Market Wire
AcelRx Pharmaceuticals, Inc. Investor Presentatio .. n-demand Viewing at RetailInvestorConferences.com
[ Fri, Jul 20th 2012 ] - Market Wire
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolisa" (carfilzomib) for Injection
[ Fri, Jul 20th 2012 ] - Market Wire
Positron Accepts Economic Incentives Offer From T .. For $30 Million Towards 70 MeV Cyclotron Project
[ Fri, Jul 20th 2012 ] - Market Wire
CONMED Corporation and Exactech to Partner in Nor .. Medical Education Programs to Treat the Continuum
[ Fri, Jul 20th 2012 ] - Market Wire
Competition in the Anti-Obesity Drug Market Growi .. as FDA Approves Second Weight Loss Drug This Year
[ Fri, Jul 20th 2012 ] - Market Wire
Arena Pharmaceuticals and VIVUS Competitors in the Lucrative Anti-Obesity Drug Market
[ Fri, Jul 20th 2012 ] - Market Wire
Equity Research on DaVita Inc. and HEALTHSOUTH Co .. pecialized Health Providers Enjoying Grace Period
Thu, July 19, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Sanofi and Regeneron Launch Comprehensive Phase 3 .. gram With LDL Cholesterol-Lowering PCSK9 Antibody
[ Thu, Jul 19th 2012 ] - Market Wire
Johnson & Johnson Provides Notice Of Proposed Set .. tive Actions, Final Settlement Hearing, And Right
[ Thu, Jul 19th 2012 ] - Market Wire
Patient Advocate Foundation and Jazz Pharmaceuticals Announce Partnership for Narcolepsy CareLine
[ Thu, Jul 19th 2012 ] - Market Wire
STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
[ Thu, Jul 19th 2012 ] - Market Wire
Johnson amp;; Johnson Provides Notice Of P .. lder Derivative Actions, Final Settlement Hearing
[ Thu, Jul 19th 2012 ] - Market Wire
Sun Healthcare Group, Inc. to Announce Second-Quarter Results for 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Amerigroup Honored by American Red Cross
[ Thu, Jul 19th 2012 ] - Market Wire
Amgen Announces 2012 Third Quarter Dividend
[ Thu, Jul 19th 2012 ] - Market Wire
Whiteknight Acquisitions Inc. Announces Commencem .. sing of Its Qualifying Transaction and Concurrent
[ Thu, Jul 19th 2012 ] - Market Wire
Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012

Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012


Published on 2012-07-19 12:16:39 - Market Wire
  Print publication without navigation


Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27,... -- STEWARTVILLE, Minn., July 19, 2012 /PRNewswire/ --

Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012

[ ]

STEWARTVILLE, Minn., July 19, 2012 /PRNewswire/ -- Rochester Medical Corporation (NASDAQ: [ ROCM ]) will announce quarterly results after financial markets close on Thursday, July 26, 2012.  The Company will then hold a quarterly conference call Friday, July 27, 2012 to discuss its earnings report.  The call will begin at 10:00 a.m. central time (11:00 p.m. eastern time).

This call is being webcast by Thomson Reuters and can be accessed at Rochester Medical's website at [ www.rocm.com ].  To listen live to the conference call via telephone, call:

Domestic:

888 680.0894

International:

617 213.4860

Pass code:

51614892

Pre Registration:

https://www.theconferencingservice.com/prereg/key.process?key=PXYJ838DM



Replay will be available for seven days at [ www.rocm.com ] or via telephone at:

Domestic:

888 286.8010

International:

617 801.6888

Pass code:

48884549

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications.  The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600.  More information about Rochester Medical is available on its website at [ http://www.rocm.com ].

SOURCE Rochester Medical Corporation



[ Back to top ]

RELATED LINKS
[ http://www.rocm.com ]

Contributing Sources